• +44 (0)161 929 0400
  • info@alpharmaxim.com
AlpharmaximAlpharmaxim
  • Our approach
  • Rare diseases
  • Client stories
  • Opinions and articles
  • Working here
  • About us
    • Veeva Content Partners
  • Get in touch
    Press enter to begin your search

    Opinions and articles

    Opinions & Articles

    The fight against anti-vaxxer misinformation

    Opinions & Articles

    Destination Altrincham: Your next career move?

    Opinions & Articles

    Can we beat the increasing danger of antimicrobial resistance?

    Opinions & Articles

    Are your internal communications struggling to be heard above the noise?

    Opinions & Articles

    Save the date and stop the itch: PFIC Awareness Day

    Opinions & Articles

    Uptake of biosimilars across Europe: A money-saver or a false hope?

    Opinions & Articles

    Does size matter? Nanomedicine: where smaller is better – but why?

    Opinions & Articles

    A smarter approach to a stronger scientific story: The Belief Continuum®

    Opinions & Articles

    Do we still need blood donors? Why blood transfusions are essential for modern healthcare

    Opinions & Articles

    World No Tobacco Day 2019

    Opinions & Articles

    Reversing dementia: One of the major challenges left to medicine

    Opinions & Articles

    The rare disease treatment explosion: Answering a huge combined unmet need

    Opinions & Articles

    World Cancer Day: Reflecting on recent advances in cancer therapy

    Opinions & Articles

    How will gene therapy be paid for?

    Opinions & Articles

    The parallels of biotech financing and the Amazon Kindle

    Opinions & Articles

    Choosing the right format for your communications

    Opinions & Articles

    Rabies: 99.9% fatal – 100% preventable

    « Previous 1 2
    abpi Member Veeva Content Partner - Multichannel CRM Rare Disease Day Pharma Tech Outlook

    +44 (0)161 929 0400

    info@alpharmaxim.com

    Get in touch

    © Alpharmaxim Healthcare Communications 2020. All rights reserved.
    Terms of use | Privacy policy | Cookies policy

    • Our approach
    • Rare diseases
    • Client stories
    • Opinions and articles
    • Working here
    • About us
      • Veeva Content Partners
    • Get in touch
    • +44 (0)161 929 0400
    • info@alpharmaxim.com